Literature DB >> 19059912

Granzyme K displays highly restricted substrate specificity that only partially overlaps with granzyme A.

Niels Bovenschen1, Razi Quadir, A Lotte van den Berg, Arjan B Brenkman, Isabel Vandenberghe, Bart Devreese, Jos Joore, J Alain Kummer.   

Abstract

Granzymes are serine proteases stored in cytolytic granules of cytotoxic lymphocytes that eliminate virus-infected and tumor cells. Little is known about the molecular mechanism and function of granzyme (Gr)K. GrK is similar to GrA in that they are the only granzymes that display tryptase-like activity. Both granzymes induce cell death by single-stranded nicking of the chromosomal DNA by cleaving the same components of the endoplasmic reticulum-associated SET complex. Therefore, GrK may provide a backup and failsafe mechanism for GrA with redundant specificity. In the present study, we addressed the question of whether GrK displays identical substrate specificity as GrA. In peptide- and protease-proteomic screens, GrK and GrA displayed highly restricted substrate specificities that overlapped only partially. Whereas GrK and GrA cleave SET with similar efficiencies likely at the same sites, both granzymes cleaved the pre-mRNA-binding protein heterogeneous ribonuclear protein K with different kinetics at distinct sites. GrK was markedly more efficient in cleaving heterogeneous ribonuclear protein K than GrA. GrK, but not GrA, cleaved the microtubule network protein beta-tubulin after two distinct Arg residues. Neither GrK cleavage sites in beta-tubulin nor a peptide-based proteomic screen revealed a clear GrK consensus sequence around the P1 residue, suggesting that GrK specificity depends on electrostatic interactions between exosites of the substrate and the enzyme. We hypothesize that GrK not only constitutes a redundant functional backup mechanism that assists GrA-induced cell death but that it also displays a unique function by cleaving its own specific substrates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059912     DOI: 10.1074/jbc.M806716200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Granzyme K-deficient mice show no evidence of impaired antiviral immunity.

Authors:  Lars T Joeckel; Cody C Allison; Marc Pellegrini; Catherina H Bird; Phillip I Bird
Journal:  Immunol Cell Biol       Date:  2017-04-21       Impact factor: 5.126

Review 3.  Daclizumab therapy for multiple sclerosis.

Authors:  Bibiana Bielekova
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

Review 4.  Daclizumab Therapy for Multiple Sclerosis.

Authors:  Bibiana Bielekova
Journal:  Cold Spring Harb Perspect Med       Date:  2019-05-01       Impact factor: 6.915

5.  Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis.

Authors:  Wenzheng Jiang; Noo Ri Chai; Dragan Maric; Bibiana Bielekova
Journal:  J Immunol       Date:  2011-06-10       Impact factor: 5.422

6.  Granzyme K inhibits replication of influenza virus through cleaving the nuclear transport complex importin α1/β dimer of infected host cells.

Authors:  C Zhong; C Li; X Wang; T Toyoda; G Gao; Z Fan
Journal:  Cell Death Differ       Date:  2011-12-02       Impact factor: 15.828

7.  Mouse granzyme K has pro-inflammatory potential.

Authors:  L T Joeckel; R Wallich; P Martin; D Sanchez-Martinez; F C Weber; S F Martin; C Borner; J Pardo; C Froelich; M M Simon
Journal:  Cell Death Differ       Date:  2011-02-11       Impact factor: 15.828

8.  Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cells.

Authors:  Alexandra C Vrazo; Adrianne E Hontz; Sarah K Figueira; Braeden L Butler; Julie M Ferrell; Brock F Binkowski; Jinzhu Li; Kimberly A Risma
Journal:  Blood       Date:  2015-06-29       Impact factor: 22.113

9.  Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytes.

Authors:  Annette C Wensink; Vera Kemp; Job Fermie; M Isabel García Laorden; Tom van der Poll; C Erik Hack; Niels Bovenschen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

10.  Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication.

Authors:  R van Domselaar; S A H de Poot; E B M Remmerswaal; K W Lai; I J M ten Berge; N Bovenschen
Journal:  Cell Death Differ       Date:  2012-10-26       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.